Anticonvulsant, anxiolytic and sedative activities of the aqueous root extract of Securidaca longepedunculata Fresen.

AIM OF THE STUDY The objective of this study is to investigate the anticonvulsant, anxiolytic and sedative activities of the aqueous root extract of Securidaca longepedunculata. MATERIALS AND METHODS The anticonvulsant effect of the aqueous root extract (100, 200 and 400 mg/kg) was evaluated in mice using the strychnine- and picrotoxin-induced seizure models. Its anxiolytic activity was evaluated using the elevated plus maze (EPM) and the Y maze (YM) methods (Hogg, 1996; Yemitan and Adeyemi, 2003) while the hexobarbitone induced sleep and the hole board models were used to evaluate the sedative and exploratory activities in mice respectively. The acute toxicity studies and phytochemical analysis of the extract were also carried out. RESULTS The extract (100-400 mg/kg) produced a significant (P<0.01) dose dependent increase in onset of convulsion compared to the control for strychnine- and picrotoxin-induced seizures. It also produced a significant (P<0.01) dose dependent prolongation of the cumulative time spent in the open arms of the elevated plus maze and Y maze compared with the control. The extract (100-400 mg/kg) produced significant (P<0.01) reduction in the time of onset of sleep induced by hexobarbitone. The prolongation of hexobarbitone sleeping time by the extract (200 mg/kg) was comparable to that produced by diazepam (3 mg/kg). At doses of 100-400 mg/kg, the extract produced a dose dependent decrease in exploratory activity of the mice. The reduction in exploratory activity produced by the extract (400 mg/kg) was greater than that of chlorpromazine (1 mg/kg). The results obtained from the experiments indicate that the extract has central nervous system depressant and anxiolytic activities. The LD(50) obtained for the acute toxicity studies using both oral and intraperitoneal routes of administration were 1.74 g/kg and 19.95 mg/kg respectively. CONCLUSION These findings justify the use of Securidaca longepedunculata in traditional medicine for the management of convulsion and psychosis.

[1]  S. File,et al.  Validation of open : closed arm entries in an elevated plus-maze as a measure of anxiety in the rat , 1985, Journal of Neuroscience Methods.

[2]  V. Kimiskidis,et al.  Depression and anxiety in epilepsy: the association with demographic and seizure-related variables , 2007, Annals of general psychiatry.

[3]  W. Stigelman,et al.  Goodman and Gilman's the Pharmacological Basis of Therapeutics , 1986 .

[4]  H. Gastaut,et al.  Dictionary of epilepsy , 1973 .

[5]  S. Curran Hypnotics and Sedatives: A Review , 1997, European Psychiatry.

[6]  R. Adebiyi,et al.  Antinociceptive and antidepressant like effects of Securidaca longepedunculata root extract in mice. , 2006, Journal of ethnopharmacology.

[7]  D. Naik,et al.  Pharmacological Studies On Sterculia Foetida Leaves , 2000, Pharmaceutical biology.

[8]  Sedative and anticonvulsant activities of the aqueous root extract of Sanseviera liberica Gerome & Labroy (Agavaceae). , 2007, Journal of ethnopharmacology.

[9]  S. Hogg A review of the validity and variability of the Elevated Plus-Maze as an animal model of anxiety , 1996, Pharmacology Biochemistry and Behavior.

[10]  B. Katzung Basic and Clinical Pharmacology , 1982 .

[11]  T. Sen,et al.  Preliminary studies on the anti-inflammatory and analgesic activity of the methanolic fraction of the root extract of Tragia involucrata Linn. , 2000, Journal of ethnopharmacology.

[12]  L. Goodman,et al.  The Pharmacological Basis of Therapeutics , 1941 .

[13]  L. Angenot,et al.  Characterization of the neurotoxicity induced by the extract of Magnistipula butayei (Chrysobalanaceae) in rat: effects of a new natural convulsive agent. , 2007, Toxicon : official journal of the International Society on Toxinology.

[14]  M. Tainter,et al.  Estimation of the ED50 and Its Error by Means of Logarithmic-Probit Graph Paper.∗ , 1944 .

[15]  G. Wickens,et al.  Non-timber uses of selected arid zone trees and shrubs in Africa , 1988 .

[16]  O. Adeyemi,et al.  Toxicological assessment of the aqueous root extract of Sanseviera liberica Gerome and Labroy (Agavaceae). , 2007, Journal of ethnopharmacology.

[17]  H. D. Neuwinger African Ethnobotany: Poisons and Drugs: Chemistry, Pharmacology, Toxicology , 1996 .

[18]  C. Sinton,et al.  CGS 19755, a selective and competitive N-methyl-D-aspartate-type excitatory amino acid receptor antagonist. , 1988, The Journal of pharmacology and experimental therapeutics.

[19]  R. Rodgers Animal models of 'anxiety': where next? , 1997, Behavioural pharmacology.

[20]  M. Casacchia,et al.  An observational study in psychiatric acute patients admitted to General Hospital Psychiatric Wards in Italy , 2007, Annals of general psychiatry.

[21]  SEDATIVE-HYPNOTIC drugs. III. The barbiturates. , 1956, The New England journal of medicine.

[22]  A. R.,et al.  The Useful Plants of West Tropical Africa , 1938, Nature.

[23]  S. File,et al.  Validity of head-dipping as a measure of exploration in a modified hole-board , 1975, Psychopharmacologia.

[24]  C. Di Giorgio,et al.  Antimalarial activity of extracts and alkaloids isolated from six plants used in traditional medicine in Mali and Sao Tome , 2002, Phytotherapy research : PTR.

[25]  Hypnotics and sedatives , 1986 .

[26]  U. Ajali,et al.  Antimicrobial activity of Securidaca longipedunculata. , 2004, Phytomedicine.

[27]  J. Sear Pharmacology, 5th Edn , 2003 .

[28]  N. Gericke,et al.  Medicinal plants of South Africa , 1998 .

[29]  G. Román,et al.  Epidemiology of epilepsy in developing countries. , 1993, Bulletin of the World Health Organization.

[30]  P. Herrling,et al.  Anticonvulsant activity of Mimosa pudica decoction. , 2004, Fitoterapia.